Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
By C. van Walraven, R. Hart, D. Singer, A. Laupacis, S. Connolly, P. Petersen, P. Koudstaal, Yuchiao Chang, B. Hellemons. Journal of the American Medical Association (JAMA), 2002
762 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/8cc0cfcf29992ce41f0861d7bbdf6698a8ece9aa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. (2010, background): “…inhibitor therapy in patients with AF provides less protection against thrombo-embolic events than does regular oral anticoagulation therapy, 2,3 the physician may choose to combine aspirin or clopidogrel with a standard anticoagulant or even to use triple therapy with aspirin,…”